Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
62
NTR.TO Quote, Financials, Valuation and Earnings
Last price:
$95.04
Seasonality move
:
2.21%
Day range:
$93.79 - $95.33
52-week range:
$65.35 - $98.67
Dividend yield:
3.2%
P/E ratio:
18.51x
P/S ratio:
1.25x
P/B ratio:
1.31x
Volume:
1.4M
Avg. volume:
2.1M
1-year change:
32.15%
Market cap:
$45.9B
Revenue:
$35.6B
EPS (TTM):
$5.13
Analysts' Opinion
-
Consensus RatingNutrien Ltd. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 9 Buy ratings, 9 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $91.81, Nutrien Ltd. has an estimated downside of -48.12% from its current price of $95.04.
-
Price Target UpsideAccording to analysts, the highest upside price target is $110.99 representing -100% upside increase from its current price of $95.04.
Fair Value
-
According to the consensus of 19 analysts, Nutrien Ltd. has -48.12% downside to fair value with a price target of $91.81 per share.
NTR.TO vs. S&P 500
-
Over the past 5 trading days, Nutrien Ltd. has overperformed the S&P 500 by 0.06% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutrien Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutrien Ltd. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Nutrien Ltd. reported revenues of $8.3B.
Earnings Growth
-
Nutrien Ltd. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Nutrien Ltd. reported earnings per share of $1.32.
Enterprise value:
64.8B
EV / Invested capital:
--
Price / LTM sales:
1.25x
EV / EBIT:
13.90x
EV / Revenue:
1.75x
PEG ratio (5yr expected):
0.12x
EV / Free cash flow:
21.69x
Price / Operating cash flow:
15.54x
Enterprise value / EBITDA:
8.10x
Gross Profit (TTM):
$11.2B
Return On Assets:
3.47%
Net Income Margin (TTM):
6.84%
Return On Equity:
7.35%
Return On Invested Capital:
4.69%
Operating Margin:
13.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $41.7B | $36.2B | $37.1B | $7.3B | $8.3B | |
| Gross Profit | $13B | $10.5B | $11.2B | $2B | $2.7B | |
| Operating Income | $6.6B | $4.2B | $4.7B | $530.6M | $1.1B | |
| EBITDA | $9.5B | $7.3B | $8B | $1.3B | $2B | |
| Diluted EPS | $5.85 | $2.02 | $5.13 | $0.05 | $1.32 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $16.1B | $22.9B | $19.1B | $18.7B | $20.1B | |
| Total Assets | $61.2B | $74B | $70.6B | $70.1B | $72.1B | |
| Current Liabilities | $10.8B | $20B | $15.3B | $14.8B | $14.3B | |
| Total Liabilities | $31.3B | $38.2B | $36.5B | $36.3B | $37.1B | |
| Total Equity | $29.9B | $35.8B | $34.1B | $33.8B | $35B | |
| Total Debt | $14.3B | $12.7B | $14.4B | $15.9B | $16.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.5B | $6.2B | $5.7B | -$1.2B | -$611.5M | |
| Cash From Investing | -$4.6B | -$3.2B | -$2.3B | -$687.6M | -$527.5M | |
| Cash From Financing | -$3.1B | -$3B | -$3.3B | $1.3B | $73.6M | |
| Free Cash Flow | $3.7B | $3.1B | $3B | -$2B | -$1.3B | |
NTR.TO
Sector
Market Cap
$45.9B
$24.1M
Price % of 52-Week High
96.32%
73.93%
Dividend Yield
3.2%
0%
Shareholder Yield
4.8%
-2.98%
1-Year Price Total Return
32.15%
21.41%
Beta (5-Year)
1.111
0.594
Dividend yield:
3.2%
Annualized payout:
$2.98
Payout ratio:
57.66%
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$94.88
200-day SMA
Buy
Level
$82.44
Bollinger Bands (100)
Buy
Level
78.57 - 89.99
Chaikin Money Flow
Buy
Level
498.6K
20-day SMA
Buy
Level
$94.14
Relative Strength Index (RSI14)
Buy
Level
56.86
ADX Line
Sell
Level
12.1
Williams %R
Neutral
Level
-60.199
50-day SMA
Buy
Level
$88.17
MACD (12, 26)
Buy
Level
26.28
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
1.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4703)
Buy
CA Score
(Annual)
Level (-0.1493)
Buy
Beneish M-Score
(Annual)
Level (-2.6556)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.7276)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nutrien Ltd. is a crop nutrient company, which engages in the production and distribution of products for agricultural, industrial, and feed customer. It operates through the following segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed, and merchandise. The Potash, Nitrogen, and Phosphate segments produces differentiated chemical nutrient contained in each products. The company was founded on June 2, 2017 and is headquartered in Saskatoon, Canada.
Stock Forecast FAQ
In the current month, NTR.TO has received 9 Buy ratings 9 Hold ratings, and 1 Sell ratings. The NTR.TO average analyst price target in the past 3 months is $91.81.
-
Where Will Nutrien Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutrien Ltd. share price will drop to $91.81 per share over the next 12 months.
-
What Do Analysts Say About Nutrien Ltd.?
Analysts are divided on their view about Nutrien Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutrien Ltd. is a Sell and believe this share price will rise from its current level to $62.86.
-
What Is Nutrien Ltd.'s Price Target?
The price target for Nutrien Ltd. over the next 1-year time period is forecast to be $91.81 according to 19 Wall Street analysts, 9 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is NTR.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutrien Ltd. is a Leans Bullish. 9 of 19 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of NTR.TO?
You can purchase shares of Nutrien Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutrien Ltd. shares.
-
What Is The Nutrien Ltd. Share Price Today?
Nutrien Ltd. was last trading at $95.04 per share. This represents the most recent stock quote for Nutrien Ltd.. Yesterday, Nutrien Ltd. closed at $95.04 per share.
-
How To Buy Nutrien Ltd. Stock Online?
In order to purchase Nutrien Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NTR.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NTR.TO
Sector
P/E ratio
18.51x
19.95x
PEG ratio
0.12x
-0.02x
P/B ratio
1.31x
1.89x
Price / LTM sales
1.25x
1.68x
Growth Metrics
NTR.TO
Sector
Revenue growth
13.42%
2.26%
Earnings growth
2552.42%
--
Revenue (5-year growth)
5.95%
3.25%
Earnings forecast
$0.67
$0.03
Profitability
NTR.TO
Sector
Profitability FY 2024
$9.2B
--
Return on invested capital
4.69%
-9.18%
Return on assets
3.47%
-10.59%
Return on equity
7.35%
-9.79%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
18
Estimated Next Earnings Date
Feb
4
Balance Sheet
NTR.TO
Sector
Total cash
$868.2M
$2.6M
Short term investments
--
$217K
Total assets
$74.6B
$16.7M
Long term debt
$16.3B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
84
VAL alert for Feb 10
Valaris Ltd. [VAL] is up 34.18% over the past day.
Sell
18
MNDY alert for Feb 10
monday.com Ltd. [MNDY] is down 20.77% over the past day.
Buy
69
GDXU alert for Feb 10
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 17.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
